The efficacy of DUPIXENT has been studied in 3 clinical trials with approximately 2,100 adults with uncontrolled moderate-to-severe atopic dermatitis.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 251 teens ages 12-17 years with uncontrolled moderate-to-severe atopic dermatitis.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 367 children ages 6-11 years with uncontrolled severe atopic dermatitis also taking topical corticosteroids.

The efficacy of DUPIXENT has been studied in a 16-week clinical trial with 162 children ages 6 months-5 years with uncontrolled moderate-to-severe atopic dermatitis also taking topical corticosteroids.

Patients enrolled in these studies were not well controlled with prescription therapies used on the skin (topical), or could not use topical therapies.